134 results
8-K
EX-99.1
PACB
Pacific Biosciences of California Inc
16 Apr 24
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
8:08am
Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including statements relating
S-8
PACB
Pacific Biosciences of California Inc
28 Feb 24
Registration of securities for employees
6:16pm
duties. They may also reduce the likelihood of derivative litigation against the Registrant’s directors and officers, even though an action
8-K
EX-99.1
PACB
Pacific Biosciences of California Inc
15 Feb 24
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
4:07pm
. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including
8-K
EX-99.1
q3nif ucyvqw6
8 Jan 24
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
8:03am
8-K
EX-99.1
z87up
30 Oct 23
PacBio Announces Third Quarter 2023 Financial Results
4:06pm
S-3ASR
zd4kjws3y31 h0f
3 Oct 23
Automatic shelf registration
4:20pm
8-K
EX-99.1
v8y8jvyltxj88gbyz6b
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.3
0uirjy3mwd9u5bo
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.2
eahle0ksqmjno219x3vo
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
2q5gxdrx
23 Jun 23
PacBio Announces a Private Convertible Exchange Transaction of $441 Million Principal Amount of 1.375% Convertible Senior Notes due 2030
7:56pm
8-K
EX-99.1
v26crbybna7
2 May 23
PacBio Announces Record Revenue in First Quarter 2023
4:03pm
8-K
EX-99.1
zw1vx us4iua2ucm1q0a
7 Nov 22
PacBio Announces Third Quarter 2022 Financial Results
4:23pm
8-K
EX-99.1
x1jav
25 Oct 22
Withdraws Guidance with New Product Announcement
9:05pm